Titre : Bloqueurs de canaux sodiques voltage-dépendants

Bloqueurs de canaux sodiques voltage-dépendants : Questions médicales fréquentes

Termes MeSH sélectionnés :

Histone Code
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Bloqueurs de canaux sodiques voltage-dépendants : Questions médicales les plus fréquentes", "headline": "Bloqueurs de canaux sodiques voltage-dépendants : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Bloqueurs de canaux sodiques voltage-dépendants : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-25", "dateModified": "2025-04-21", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Bloqueurs de canaux sodiques voltage-dépendants" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Bloqueurs de canaux sodiques", "url": "https://questionsmedicales.fr/mesh/D026941", "about": { "@type": "MedicalCondition", "name": "Bloqueurs de canaux sodiques", "code": { "@type": "MedicalCode", "code": "D026941", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.411.720" } } }, "about": { "@type": "MedicalCondition", "name": "Bloqueurs de canaux sodiques voltage-dépendants", "alternateName": "Voltage-Gated Sodium Channel Blockers", "code": { "@type": "MedicalCode", "code": "D061567", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "William A Catterall", "url": "https://questionsmedicales.fr/author/William%20A%20Catterall", "affiliation": { "@type": "Organization", "name": "Department of Pharmacology, University of Washington, Seattle, WA 98195, USA. Electronic address: wcatt@uw.edu." } }, { "@type": "Person", "name": "Piyasuda Pukkanasut", "url": "https://questionsmedicales.fr/author/Piyasuda%20Pukkanasut", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, The University of Alabama at Birmingham, Birmingham, AL 35294, USA." } }, { "@type": "Person", "name": "Sadanandan E Velu", "url": "https://questionsmedicales.fr/author/Sadanandan%20E%20Velu", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, The University of Alabama at Birmingham, Birmingham, AL 35294, USA." } }, { "@type": "Person", "name": "Tamer M Gamal El-Din", "url": "https://questionsmedicales.fr/author/Tamer%20M%20Gamal%20El-Din", "affiliation": { "@type": "Organization", "name": "Department of Pharmacology, University of Washington, Seattle, WA, United States." } }, { "@type": "Person", "name": "Christopher L-H Huang", "url": "https://questionsmedicales.fr/author/Christopher%20L-H%20Huang", "affiliation": { "@type": "Organization", "name": "Department of Biochemistry, Hopkins Building, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QW, UK." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "A short peptide encoded by long non-coding RNA small nucleolar RNA host gene 6 promotes cell migration and epithelial-mesenchymal transition by activating transforming growth factor-beta/SMAD signaling pathway in human endometrial cells.", "datePublished": "2022-11-17", "url": "https://questionsmedicales.fr/article/36396030", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/jog.15476" } }, { "@type": "ScholarlyArticle", "name": "Discrepancies in ICD-9/ICD-10-based codes used to identify three common diseases in cancer patients in real-world settings and their implications for disease classification in breast cancer patients and patients without cancer: a literature review and descriptive study.", "datePublished": "2023-09-06", "url": "https://questionsmedicales.fr/article/37746274", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fonc.2023.1016389" } }, { "@type": "ScholarlyArticle", "name": "Are Patients With an International Classification of Diseases, 10th Edition Discharge Diagnosis Code for Sepsis Different in Regard to Demographics and Outcome Variables When Comparing Those With Sepsis Only to Those Also Diagnosed With COVID-19 or Those With a COVID-19 Diagnosis Alone?", "datePublished": "2023-08-25", "url": "https://questionsmedicales.fr/article/37644976", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/CCE.0000000000000964" } }, { "@type": "ScholarlyArticle", "name": "Long Non-Coding RNA Nuclear-Enriched Abundant Transcript 1 (NEAT1) Facilitates Foam Cell Formation and Atherosclerosis Progression Through the miR-17-5p/Itchy E3 Ubiquitin Protein Ligase (ITCH)/Liver Kinase B1 (LKB1) Axis.", "datePublished": "2024-04-16", "url": "https://questionsmedicales.fr/article/38631864", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1253/circj.CJ-23-0769" } }, { "@type": "ScholarlyArticle", "name": "Understanding context of violence against healthcare through citizen science and evaluating the effectiveness of a co-designed code of conduct and of a tailored de-escalation of violence training in Eastern Democratic Republic of Congo and Iraq: a study protocol for a stepped wedge randomized controlled trial.", "datePublished": "2023-12-19", "url": "https://questionsmedicales.fr/article/38110997", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13063-023-07839-3" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Actions chimiques et utilisations", "item": "https://questionsmedicales.fr/mesh/D020164" }, { "@type": "ListItem", "position": 3, "name": "Actions pharmacologiques", "item": "https://questionsmedicales.fr/mesh/D020228" }, { "@type": "ListItem", "position": 4, "name": "Utilisations thérapeutiques", "item": "https://questionsmedicales.fr/mesh/D045506" }, { "@type": "ListItem", "position": 5, "name": "Agents cardiovasculaires", "item": "https://questionsmedicales.fr/mesh/D002317" }, { "@type": "ListItem", "position": 6, "name": "Bloqueurs de canaux sodiques", "item": "https://questionsmedicales.fr/mesh/D026941" }, { "@type": "ListItem", "position": 7, "name": "Bloqueurs de canaux sodiques voltage-dépendants", "item": "https://questionsmedicales.fr/mesh/D061567" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Bloqueurs de canaux sodiques voltage-dépendants - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Bloqueurs de canaux sodiques voltage-dépendants", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-19", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Bloqueurs de canaux sodiques voltage-dépendants", "description": "Comment diagnostiquer une intoxication aux bloqueurs de canaux sodiques ?\nQuels tests sont utilisés pour évaluer l'effet des bloqueurs ?\nQuels symptômes indiquent une surdose de bloqueurs ?\nComment différencier les types de bloqueurs de canaux ?\nQuels antécédents médicaux sont pertinents pour le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D061567?mesh_terms=Histone+Code&page=747#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Bloqueurs de canaux sodiques voltage-dépendants", "description": "Quels sont les symptômes d'une intoxication aiguë ?\nComment se manifestent les effets secondaires des bloqueurs ?\nQuels signes indiquent une réaction allergique ?\nLes bloqueurs affectent-ils la respiration ?\nQuels symptômes neurologiques peuvent apparaître ?", "url": "https://questionsmedicales.fr/mesh/D061567?mesh_terms=Histone+Code&page=747#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Bloqueurs de canaux sodiques voltage-dépendants", "description": "Comment prévenir les effets indésirables des bloqueurs ?\nQuelles précautions doivent être prises avant la prescription ?\nLes patients doivent-ils être informés des risques ?\nComment éviter les interactions médicamenteuses ?\nQuelles sont les recommandations pour les patients à risque ?", "url": "https://questionsmedicales.fr/mesh/D061567?mesh_terms=Histone+Code&page=747#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Bloqueurs de canaux sodiques voltage-dépendants", "description": "Quel est le traitement d'une surdose de bloqueurs ?\nComment gérer les effets secondaires des bloqueurs ?\nQuels médicaments peuvent interagir avec les bloqueurs ?\nLes bloqueurs sont-ils utilisés en anesthésie ?\nQuelle est l'importance de la surveillance pendant le traitement ?", "url": "https://questionsmedicales.fr/mesh/D061567?mesh_terms=Histone+Code&page=747#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Bloqueurs de canaux sodiques voltage-dépendants", "description": "Quelles complications peuvent survenir avec les bloqueurs ?\nComment les complications sont-elles gérées ?\nLes complications sont-elles fréquentes ?\nQuels facteurs augmentent le risque de complications ?\nLes complications peuvent-elles être évitées ?", "url": "https://questionsmedicales.fr/mesh/D061567?mesh_terms=Histone+Code&page=747#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Bloqueurs de canaux sodiques voltage-dépendants", "description": "Quels sont les principaux facteurs de risque ?\nComment l'âge influence-t-il le risque ?\nLes antécédents familiaux jouent-ils un rôle ?\nL'usage de drogues illicites est-il un facteur de risque ?\nLes maladies neurologiques augmentent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D061567?mesh_terms=Histone+Code&page=747#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une intoxication aux bloqueurs de canaux sodiques ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic repose sur l'historique médical, les symptômes cliniques et des tests sanguins." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'effet des bloqueurs ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des électrocardiogrammes et des tests de conduction nerveuse peuvent être utilisés." } }, { "@type": "Question", "name": "Quels symptômes indiquent une surdose de bloqueurs ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des convulsions, une arythmie cardiaque et une dépression respiratoire peuvent survenir." } }, { "@type": "Question", "name": "Comment différencier les types de bloqueurs de canaux ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'analyse des effets cliniques et des mécanismes d'action aide à les différencier." } }, { "@type": "Question", "name": "Quels antécédents médicaux sont pertinents pour le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents de maladies cardiaques ou neurologiques sont cruciaux pour le diagnostic." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une intoxication aiguë ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des vertiges, des nausées, des troubles de la vision et des convulsions." } }, { "@type": "Question", "name": "Comment se manifestent les effets secondaires des bloqueurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent provoquer des étourdissements, des maux de tête et des troubles de la coordination." } }, { "@type": "Question", "name": "Quels signes indiquent une réaction allergique ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des éruptions cutanées, des démangeaisons et un gonflement peuvent signaler une allergie." } }, { "@type": "Question", "name": "Les bloqueurs affectent-ils la respiration ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent entraîner une dépression respiratoire dans les cas graves." } }, { "@type": "Question", "name": "Quels symptômes neurologiques peuvent apparaître ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des convulsions, des troubles de la conscience et des paralysies peuvent survenir." } }, { "@type": "Question", "name": "Comment prévenir les effets indésirables des bloqueurs ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une prescription appropriée et une éducation du patient sont essentielles pour prévenir les effets indésirables." } }, { "@type": "Question", "name": "Quelles précautions doivent être prises avant la prescription ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Évaluer les antécédents médicaux et les allergies du patient est crucial avant la prescription." } }, { "@type": "Question", "name": "Les patients doivent-ils être informés des risques ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, informer les patients des risques et des signes d'intoxication est essentiel." } }, { "@type": "Question", "name": "Comment éviter les interactions médicamenteuses ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Un examen minutieux des médicaments prescrits et des antécédents est nécessaire pour éviter les interactions." } }, { "@type": "Question", "name": "Quelles sont les recommandations pour les patients à risque ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les patients à risque doivent être suivis de près et éduqués sur les signes d'alerte." } }, { "@type": "Question", "name": "Quel est le traitement d'une surdose de bloqueurs ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement inclut des soins de soutien, l'administration de charbon actif et des antidotes si disponibles." } }, { "@type": "Question", "name": "Comment gérer les effets secondaires des bloqueurs ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La gestion implique l'ajustement de la dose ou le changement de médicament selon les symptômes." } }, { "@type": "Question", "name": "Quels médicaments peuvent interagir avec les bloqueurs ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments comme les antidépresseurs et les anesthésiques peuvent interagir." } }, { "@type": "Question", "name": "Les bloqueurs sont-ils utilisés en anesthésie ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains bloqueurs de canaux sodiques sont utilisés pour induire une anesthésie locale." } }, { "@type": "Question", "name": "Quelle est l'importance de la surveillance pendant le traitement ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La surveillance est cruciale pour détecter les effets indésirables et ajuster le traitement." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec les bloqueurs ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme des arythmies, des convulsions et des défaillances respiratoires peuvent survenir." } }, { "@type": "Question", "name": "Comment les complications sont-elles gérées ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "La gestion des complications nécessite une intervention rapide et un traitement symptomatique." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les complications sont rares mais peuvent survenir, surtout en cas de surdose ou d'interactions." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de complications ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs comme l'âge avancé, les maladies cardiaques et l'utilisation concomitante d'autres médicaments augmentent le risque." } }, { "@type": "Question", "name": "Les complications peuvent-elles être évitées ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Une surveillance attentive et une éducation adéquate peuvent aider à prévenir certaines complications." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents de maladies cardiaques, l'âge et l'utilisation d'autres médicaments sont des facteurs de risque." } }, { "@type": "Question", "name": "Comment l'âge influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes âgées ont un risque accru de complications en raison de la polypharmacie et de la fragilité." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de maladies cardiaques ou neurologiques peuvent augmenter le risque." } }, { "@type": "Question", "name": "L'usage de drogues illicites est-il un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'usage de certaines drogues peut interagir avec les bloqueurs et augmenter le risque d'effets indésirables." } }, { "@type": "Question", "name": "Les maladies neurologiques augmentent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les patients ayant des maladies neurologiques peuvent être plus sensibles aux effets des bloqueurs." } } ] } ] }

Sources (7470 au total)

A short peptide encoded by long non-coding RNA small nucleolar RNA host gene 6 promotes cell migration and epithelial-mesenchymal transition by activating transforming growth factor-beta/SMAD signaling pathway in human endometrial cells.

Endometrial dysfunction is closely correlated with the development of multiple severe gynecological disorders including intrauterine adhesion. Accumulating evidence supports that some long non-coding ... The peptide-encoding potential of SNHG6 was predicted by FuncPEP and getorf databases and validated by western blot assay. Cell viability was tested by cell counting kit-8 assay. Cell migratory abilit... Prediction analysis suggested that SNHG6 had the potential peptide-coding ability and multiple open-reading frames (ORFs). Western blot validated that SNHG6 ORF#1 and ORF#2 could translate into short ... LncRNA SNHG6 ORF#1 and ORF#2 could translate into small peptides and SNHG6 ORF#2 overexpression promoted cell migration and EMT by activating the TGF-β/SMAD pathway in hESCs and hEECs, suggesting the ...

Discrepancies in ICD-9/ICD-10-based codes used to identify three common diseases in cancer patients in real-world settings and their implications for disease classification in breast cancer patients and patients without cancer: a literature review and descriptive study.

International Classification of Diseases, Ninth/Tenth revisions, clinical modification (ICD-9-CM, ICD-10-CM) are frequently used in the U.S. by health insurers and disease registries, and are often re... A literature search was performed (Embase, Medline) to find sources reporting ICD codes for at least one disease of interest. Articles were screened in two levels (title/abstract; full text). Analysis... Of 106 references identified, 29 were included that reported 884 codes (155 anemia, 80 hypertension, 649 arthritis). Overall discordance between the gold standard and literature/web search code list w... Discrepancies in codes used to identify three common diseases resulted in variable differences in disease classification. In all cases, the gold standard captured patients missed using the literature/...

Are Patients With an International Classification of Diseases, 10th Edition Discharge Diagnosis Code for Sepsis Different in Regard to Demographics and Outcome Variables When Comparing Those With Sepsis Only to Those Also Diagnosed With COVID-19 or Those With a COVID-19 Diagnosis Alone?

We analyzed whether patients with the International Classification of Diseases, 10th Edition (ICD-10) discharge diagnosis code for sepsis are different in regard to demographics and outcome variables ... Retrospective cohort study.... Nine hospitals in an academic health system.... Patients with a final ICD-10 discharge diagnostic code for sepsis only, a diagnosis of COVID-19-only, or a final sepsis ICD-10 discharge code + a diagnosis of COVID-19 admitted to the hospital were an... None.... A total of 11,395 patients met inclusion criteria: 6,945 patients (60.9%) were ICD-10 sepsis code only, 3,294 patients (28.9%) were COVID-19 diagnosis-only, and 1,153 patients (10.1%) were sepsis ICD-... During the COVID-19 pandemic the sickest cohort of patients was those receiving an explicit ICD-10 code of sepsis + a COVID-19 diagnosis. A significant percentage of COVID-19 diagnosis-only patients a...

Long Non-Coding RNA Nuclear-Enriched Abundant Transcript 1 (NEAT1) Facilitates Foam Cell Formation and Atherosclerosis Progression Through the miR-17-5p/Itchy E3 Ubiquitin Protein Ligase (ITCH)/Liver Kinase B1 (LKB1) Axis.

Foam cell formation is an important step for atherosclerosis (AS) progression. We investigated the mechanism by which the long non-coding RNA (lncRNA) nuclear-enriched abundant transcript 1 (NEAT1) re... NEAT1 accelerated foam cell formation during AS progression through the miR-17-5p/ITCH/LKB1 axis....

Understanding context of violence against healthcare through citizen science and evaluating the effectiveness of a co-designed code of conduct and of a tailored de-escalation of violence training in Eastern Democratic Republic of Congo and Iraq: a study protocol for a stepped wedge randomized controlled trial.

Violence against health care workers (HCWs) is a multifaceted issue entwined with broader social, cultural, and economic contexts. While it is a global phenomenon, in crisis settings, HCWs are exposed... In an initial formative research phase, the study will use a transdisciplinary citizen science approach to inform the re-adaptation of a violence de-escalation training for HCWs and the content of a c... Violence against HCWs is a global issue, and it can be particularly severe in humanitarian contexts. However, there is limited evidence on effective and affordable approaches to address this problem. ... ClinicalTrial.gov Identifier NCT05419687. Prospectively registered on June 15, 2022....

Long non-coding RNA nuclear paraspeckle assembly transcript 1 downregulation protects lens epithelial cells from oxidative stress-induced apoptosis by regulating the microRNA-124-3p/death-associated protein kinase 1 axis in age-related cataract.

Oxidative stress plays a significant role in cataract development. It causes the apoptosis of lens epithelial cells (LECs), resulting in lens opacification and accelerating cataract progression. Long ...

How does Injury Severity Score derived from International Classification of Diseases Programs for Injury Categorization using International Classification of Diseases, Tenth Revision, Clinical Modification codes perform compared with Injury Severity Score derived from Trauma Quality Improvement Program?

Injury Severity Score (ISS) is a measurement of injury severity based on the Abbreviated Injury Scale. Because of the difficulty and expense of Abbreviated Injury Scale coding, there have been recent ... This was an observational cohort study of 1,040,728 encounters in the TQIP registry for the year 2018. International Classification of Diseases Programs for Injury Categorization in R was used to deri... The median difference between ISS calculated by ICDPIC-2021 using ICD-10, Clinical Modification (ISS-ICDPIC), and manually derived ISS was -3 (95% confidence interval, -5 to 0), while the mean differe... When TQIP data are unavailable, ICDPIC remains a valid way to calculate ISS after transition to ICD-10 codes. The ISS-ICDPIC performs well in predicting a number of outcomes of interest but is best se... Prognostic and Epidemiological; Level III....

Description of two cultivated and two uncultivated new Salinibacter species, one named following the rules of the bacteriological code: Salinibacter grassmerensis sp. nov.; and three named following the rules of the SeqCode: Salinibacter pepae sp. nov., Salinibacter abyssi sp. nov., and Salinibacter pampae sp. nov.

Current -omics methods allow the collection of a large amount of information that helps in describing the microbial diversity in nature. Here, and as a result of a culturomic approach that rendered th...